InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by McAvoy David R., Conseiller Juridique et Directeur de la Conformité. Officer active across 2 companies, notably Brickell Biotech, Inc.. In total, 4 filings have been recorded. Total volume traded: €45k. The latest transaction was disclosed on 23 July 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
€10,31018,124 shares@ €0.5689100.0% of flow
Common Stock
SEC:0000819050-21-000124·
Ideal exit: 19 Apr 2022 (T+270)
€10,31018,124 shares@ €0.568929.6% of flow
Common Stock
SEC:0000819050-21-000124:0·
Ideal exit: 19 Apr 2022 (T+270)
€12,25418,622 shares@ €0.6581100.0% of flow
Common Stock
SEC:0001062993-21-004867·
Ideal exit: 11 Feb 2022 (T+270)
€12,25418,622 shares@ €0.658135.2% of flow
Common Stock
SEC:0001062993-21-004867:0·
Ideal exit: 11 Feb 2022 (T+270)
4 of 4 declarations
About McAvoy David R.
David R. McAvoy is General Counsel and Chief Compliance Officer at Brickell Biotech, Inc., a company specializing in the development of biopharmaceutical therapies. In this role, he is responsible for legal and compliance matters, ensuring that the company adheres to applicable regulations.
